Cargando…
PROTACs: The Future of Leukemia Therapeutics
The fight to find effective, long-lasting treatments for cancer has led many researchers to consider protein degrading entities. Recent developments in PROteolysis TArgeting Chimeras (PROTACs) have signified their potential as possible cancer therapies. PROTACs are small molecule, protein degraders...
Autores principales: | Anwar, Zubair, Ali, Muhammad Shahzad, Galvano, Antonio, Perez, Alessandro, La Mantia, Maria, Bukhari, Ihtisham, Swiatczak, Bartlomiej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479449/ https://www.ncbi.nlm.nih.gov/pubmed/36120561 http://dx.doi.org/10.3389/fcell.2022.851087 |
Ejemplares similares
-
Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023) -
Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023) -
Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
por: Liu, Jing, et al.
Publicado: (2021) -
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022) -
Fast-Track and Integration-Free Method of Genome Editing by CRISPR/Cas9 in Murine Pluripotent Stem Cells
por: Mamun, Md Mahfuz Al, et al.
Publicado: (2022)